AXCELON ENTERS INTO A CANADIAN DISTRIBUTION AGREEMENT WITH THE STEVENS COMPANY FOR NANODERM™
Toronto, Ontario, March 19th, 2015. Axcelon Biopolymers Corp. (ABC) announced today that its majority owned…
Company News
Company News
Canadian life sciences companies team up to develop the first medical grade biotech protective facial mask for COVID-19
MONTREAL, June 8, 2020 /CNW Telbec/ – Arylide Life Sciences Inc. and Axcelon Biopolymers Corp.…
Axcelon Biopolymers Corp. (ABC) announced today that it is contemplating building its demonstration bacterial nanocellulose (BNC) production facility in St. Félicien, Qc.
St. Félicien, Quebec, February 21, 2017. Axcelon Biopolymers Corp. (ABC) announced today that it is…
AXCELON ANNOUNCES ISSUANCE OF A MAJOR US PATENT FOR BIOMEDICAL APPLICATIONS OF BACTERIAL CELLULOSE COMPOSITE
London, Ontario, November 19th, 2015. Axcelon Biopolymers Corp. (ABC) announced today that the US Patent…
AXCELON BIOPOLYMERS CORP. ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING IN ITS WOUNDCARE SUBSIDIARY
Toronto, Ontario , November25, 2014. Axcelon Biopolymers Corp. (ABC) announced today that a private placement…
AXCELON BIOPOLYMERS CORP. ANNOUNCES HEALTH CANADA LICENSE FOR ITS LEAD WOUNDCARE PRODUCT NANODERM©
London, Ontario, July 25th, 2014. Axcelon Biopolymers Corp., a biomaterials company developing biocellulose based products for…
AXCELON BIOPOLYMERS CORP. ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING IN ITS WOUNDCARE SUBSIDIARY LONDON
London, Ontario, July 25th, 2014. Axcelon Biopolymers Corp., a biomaterials company developing biocellulose based products for…
Leo Acquisitions Corp. Enters Into Letter of Intent With Axcelon Biopolymers Inc. in Respect of a Proposed Qualifying Transaction
Leo Acquisitions Corp. Enters Into Letter of Intent With Axcelon Biopolymers Inc. in Respect of…